Jim Weissman Martha Shadan Steve Dickman Andrew Miller Kristin King-Jankiewicz

(2.22) Into The Unknown: Planning Your Startup’s Exit Strategy

A Talk by Kristin King-Jankiewicz , Steve Dickman , Martha Shadan , Jim Weissman and Andrew Miller

Proudly supported by

About this Talk

While it may seem a bit like putting the cart before the horse, it is important to start envisioning the exit you’d like for your startup long before the time comes. Exploring exit-strategies for startups help founders and executives avoid pitfalls and successfully position the startup in a place to maximize valuation and ensure a successful exit.

Which is why we’re tackling your questions, such as: 

  • What exit strategies are most favorable for late-stage startups?
  • What is the difference in preparing your startup for an IPO vs acquisition? 
  • What legal and financial preparations are critical for a smooth exit?
  • How can founders maximize valuation at exit?
  • What are common pitfalls in the exit process and how to avoid them?

This session is part of Startup Boston Week 2024 and is perfect for Founders and executives aiming for a successful exit (acquisition or IPO)

September 10, 2024, 10:00 PM

10:00 PM - 11:00 PM

About The Speakers

Kristin King-Jankiewicz

Kristin King-Jankiewicz

Head of Group Management, Boston Harbor Angels

Kristin King is Head of Group Management, Boston Harbor Angels, and an active angel investor.


Steve Dickman

Steve Dickman

CEO, CBT Advisors

CBT Advisors CEO Steve Dickman has worked in consulting and venture capital for more than twenty-five years.


Martha Shadan

Martha Shadan

Serial Entrepreneur and Board Member

Martha Shadan was the president and chief executive officer at Miach Orthopaedics from 2019 to 2022.


Jim Weissman

Jim Weissman

Former, COO/CBO Dicerna Pharmaceuticals

Jim Weissman has more than 30 years’ experience in the life sciences industry including business and corporate development, general management, marketing, M&A, new product planning and development, and other operating activities.


Andrew Miller

Andrew Miller

Founder and former President of R&D, Karuna Therapeutics

Dr. Miller is a highly accomplished biopharmaceutical executive with expertise in neuroscience research and development and corporate strategy

Location

Suffolk University

120 Tremont Street, Boston

Commons - 5th Floor

Suffolk University

Main Sponsor

Suffolk University's Sawyer Business School

The Sawyer Business School occupies an unrivaled position at the nexus of Boston’s private, public, and nonprofit sectors. Our learners enjoy unparalleled access to the city’s financial and innovation clusters, seats of government, nonprofit organizations, and world-class healthcare institutions.

Main Sponsor

Want to sponsor this event? Contact Startup Boston